Medication info
Limetpol Tablet 2/500 mg (Glimepiride, Metformin)

Limetpol Tablet 2/500 mg (Glimepiride, Metformin)

Prescription medicationTabletOral
Ingredient · strength
Metformin Hydrochloride›500mg / 1 tabletGlimepiride›2mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceuticals Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
300 tablets/bottle, 30 tablets/bottle
Approval status
Active

MFDS item code 201803772 · Approved 2018.09.20 · Insurance code 622803280

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer this drug immediately before or with meals 1~2 times daily. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg; based on blood glucose monitoring results, the dose was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer according to the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Ingredients

Manufacturer
Mothers Pharmaceuticals Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

View approved original text

This medication is used to assist in controlling blood glucose levels in patients with type 2 diabetes through the combined administration of glimepiride and metformin. It is effective in managing diabetes by improving blood sugar levels in conjunction with dietary and exercise therapies.

How to take

Adult dose

Administer this drug immediately before or with meals 1~2 times daily. The dose may be adjusted based on each patient's current treatment regimen, efficacy, and tolerability; appropriate blood glucose monitoring should be performed for this purpose. Treatment is usually initiated at a low dose, which may be adjusted based on the patient's current medications and blood glucose levels. In clinical trials, the initial daily dose was glimepiride/metformin hydrochloride 2mg/500mg; based on blood glucose monitoring results, the dose was gradually increased up to glimepiride/metformin hydrochloride 8mg/2000mg. With glimepiride as a single agent, there is generally little additional benefit at doses above 4mg per day, although some patients achieved better metabolic control when the dose was increased to 6mg (or 8mg). When used as a substitute for combination therapy, administer according to the dosage and administration of glimepiride and metformin hydrochloride currently being taken in combination. Even if a previous dose was missed, do not take more than a single dose at the next scheduled dose.

Precautions

This medication can cause severe lactic acidosis or hypoglycemia; therefore, it should be temporarily discontinued if there is a rapid decline in kidney function or dehydration symptoms. It should not be given to patients with a kidney function below 45 mL/min/1.73m2, and caution should be exercised when the renal function is expected to fluctuate. As there is an increased risk of cardiovascular mortality in diabetic patients, careful counseling regarding the risks and benefits of this drug and other treatments is necessary. It should not be administered to patients with insulin-dependent diabetes, acute metabolic acidosis, severe hepatic dysfunction, pregnant or nursing women, and patients with severe renal impairment. There is a higher risk of hypoglycemia during the initial dosing period, so caution is especially warranted for patients with poor nutritional status, irregular meals, strenuous exercise, or alcohol intake. Gastrointestinal disturbances (such as diarrhea, nausea, vomiting, etc.) may occur, which are usually temporary, but if severe, medical consultation should be sought. If allergic reactions or severe skin rashes occur, discontinue use immediately and inform a healthcare professional. Long-term use may cause vitamin B12 deficiency, so regular blood tests are necessary. Interactions with other medications are frequent; therefore, consultation with a physician or pharmacist is essential before starting or stopping other drugs. Women who are pregnant or planning to become pregnant should not use this medication, and nursing mothers should avoid it as well. Elderly patients may have an increased risk of side effects due to decreased renal function; thus, dose adjustments and regular renal function tests are required. In case of overdose, hypoglycemia or lactic acidosis may occur, so it is crucial to adhere strictly to the prescribed dosage, and if unusual symptoms arise, immediate medical attention should be sought. This medication requires caution when driving or operating machinery and should be kept out of reach of children.

Side effects

Lactic acidosis, hypoglycemia, diarrhea, nausea, vomiting, abdominal distension, loss of appetite, dyspepsia, constipation, abdominal pain, metallic taste, visual impairment, taste disorders, erythema, pruritus, urticaria, rash, thrombocytopenia, leukopenia, hemolytic anemia, anemia, agranulocytosis, pancytopenia, peripheral neuropathy, elevated liver enzymes, liver dysfunction, biliary secretion disorder, jaundice, hepatitis, allergic vasculitis, photosensitivity, decreased serum sodium concentration, decreased thyroid-stimulating hormone level, magnesium deficiency during diarrhea, encephalopathy, hair loss, weight gain, symptoms of hypoglycemia (headache, severe hunger, nausea, vomiting, fatigue, drowsiness, weakness, somnolence, sleep disturbances, instability, aggressiveness, attention deficit, inability to focus, abnormal reactions, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, paralysis, sensory disturbances, dizziness, inability to self-regulate, delirium, cerebral convulsions, loss of consciousness, coma, weak breathing, slow pulse, sweating, moist skin, anxiety, rapid pulse, hypertension, palpitations, angina, deep vein thrombosis)

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container that allows for proper ventilation and stored at room temperature between 1 to 30 degrees Celsius. This storage method helps maintain the drug's effectiveness and prevent deterioration.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

300 tablets/bottle, 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.